Prostate Screening: American Cancer Society Updates Guidance for Men
New rules recommend biennial PSA tests for average-risk men and annual testing starting at age 45 for high-risk individuals, reversing a decade-old advisory.
By Marco Ortega ·

The American Cancer Society issued new recommendations on Thursday for prostate cancer screening, moving away from a shared decision-making model toward specific testing schedules for men. The updated guidelines advise men at average risk to undergo the prostate-specific antigen, or PSA, blood test every two years between the ages of 50 and 69.
For men considered high-risk, the society recommends starting screening earlier and more frequently. This group includes Black men and those with a strong family history of the disease. These individuals should begin testing at age 45 and receive the PSA test annually.
The society defined a strong family history as having one close relative, such as a father, brother, or son, diagnosed with prostate cancer before age 65, or multiple close relatives diagnosed at any age. Men with only one close relative diagnosed after 65 should start screening at 45 but may wait two years between tests.
This shift reverses guidance in place since 2010, which instructed average-risk men to discuss the pros and cons of testing with their doctors rather than following a strict schedule. The change reflects new data suggesting that regular testing can detect the disease before it spreads, making treatment more effective.
Prostate cancer is highly survivable when caught early, but previous widespread testing led to overtreatment of slow-growing tumors and unnecessary follow-ups. The society stated that the new advice balances the benefits of early detection with steps to reduce harm, such as repeating tests to confirm high readings and using MRI scans to identify who needs a biopsy.
Dr. Ash Tewari, a prostate cancer specialist at Mount Sinai's Icahn School of Medicine in New York, noted that the change simplifies the process for primary care doctors. "This has taken ambiguity out of it. They are basically saying, 'Do it,'" Tewari said. He added that the guideline will likely help more men stay healthy enough to spend more time with their families.
The society maintains that a conversation between doctor and patient remains necessary to weigh the benefits and risks. Dr. Céline Gounder, a medical correspondent, explained that the timeline for treatment has changed. "It takes about 10 years from when you diagnose prostate cancer to until somebody may need surgery, and we do much more watching and waiting, so it makes sense now you can be a little more aggressive with the PSA," Gounder said.
The guidelines also address the duration of screening. Testing is not recommended for men whose health is so poor that they are not expected to live another 10 years. Men should discuss the choice with a doctor at age 70, as benefits become less clear at that stage. The society no longer recommends screening at 75, though particularly healthy men aged 75 to 79 may continue, and testing is discouraged after age 80.
The society estimates that more than 333,000 men in the United States will be diagnosed with prostate cancer in 2026, with about 36,000 deaths expected from the disease. Most cases show no symptoms early on, but signs can include changes in urination, blood in urine or semen, and lower body pain, often resulting from a tumor pressing on the urinary tract.
More News · National news · Report a business · Got a Story?






